Table 2 Baseline clinical, Laboratory, ART and other medication related information of HIV patients on chronic HIV care at Debre-Markos Referral Hospital, Northwest Ethiopia
Characteristics | Frequency (N) | Percentage (%) |
|---|---|---|
WHO clinical staging | ||
 I / II | 304 | 61.8 |
 III /IV | 188 | 38.2 |
CD4 count | ||
 <  100 | 113 | 23.0 |
 100–200 | 123 | 25.1 |
 201–350 | 140 | 28.5 |
 > = 351 | 115 | 23.4 |
Functional status | ||
 Working | 418 | 85.1 |
 Ambulatory /bed redden | 73 | 14.9 |
Hemoglobin level | ||
 <  10 g/dl | 44 | 9.6 |
 > = 10 g/gl | 416 | 90.4 |
BMI/MUAC | ||
 Underweight | 145 | 29.5 |
 Not Underweight | 347 | 70.5 |
Eligible criteria | ||
 CD4 cell count | 199 | 40.5 |
 WHO stage | 49 | 10.0 |
 Both | 116 | 23.6 |
 Test & treat | 89 | 18.2 |
 Not recorded | 38 | 7.7 |
Initial regimen | ||
 1d = ZDV-3TC EFV | 11 | 2.2 |
 1c = ZDV-3TC- NVP | 36 | 7.3 |
 1e = TDF-3TC-EFV | 423 | 86.2 |
 1f = TDF-3TF-NVP | 15 | 3.1 |
 Other | 6 | 1.2 |
Past TB history | ||
 Yes | 7 | 1.4 |
 No | 483 | 98.6 |